Pfizer
99,665
$34.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$34.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.04 (+3.18%) Today
+$0.54 (+1.60%) As of 4:57 AM EDT after-hours
Why Robinhood?
You can buy or sell Pfizer and other stocks, options, ETFs, and crypto commission-free!
About PFE
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. Read More The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Employees
88,300
Headquarters
New York, New York
Founded
1849
Market Cap
187.42B
Price-Earnings Ratio
11.70
Dividend Yield
4.53
Average Volume
36.82M
High Today
$34.53
Low Today
$33.72
Open Price
$34.51
Volume
69.73M
52 Week High
$44.56
52 Week Low
$27.88
Collections
Digestible Financial News
Jack Kramer & Nick Martell
Managing Editors of News & Snacks at Robinhood Financial LLC
PFE News
MarketWatch13h
After months of speculation, investors get excited about Pfizer, BioNTech’s coronavirus vaccine candidate
The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of early-stage clinical data for two vaccine cand
Analyst Ratings
50%
of 16 ratings
Buy
50%
Hold
50%
Sell
0%
PFE Earnings
$0.00
$0.28
$0.57
$0.85
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Available Jul 28, Pre-Market
You May Also Like
More PFE News
Benzinga16h
Pfizer, BioNTech Report Promising Initial Data From Coronavirus Vaccine Study
Pfizer Inc. (NYSE: PFE), which is one of the five companies shortlisted by the U.S. government's Operation Warp Speed coronavirus vaccine program, reported posi
Bloomberg18h
Virus Shot From Pfizer, BioNtech Shows Promise in Early Test
(Bloomberg) -- An early trial of an experimental coronavirus vaccine from Pfizer Inc. and BioNtech SE showed it’s safe and prompted patients to produce antibodi
MarketWatch18h
Dow jumps 25 points on gains for Pfizer, Walt Disney stocks
DOW UPDATE Led by positive momentum for shares of Pfizer and Walt Disney, the Dow Jones Industrial Average is climbing Wednesday morning. Shares of Pfizer (PFE)
Benzinga19h
A Look Into Pfizer's Price Over Earnings
In the current market session, Pfizer Inc. (NYSE: PFE) is trading at $34.13, after a 4.34% increase. However, over the past month, the stock decreased by 5.63%,
MarketWatch19h
BioNTech's stock halted, Pfizer shares jump on promising COVID-19 vaccine data
BioNTech's BNTX, +1.42% stock was halted and shares of Pfizer Inc. PFE, +3.67% gained 4.7% in trading on Wednesday morning after the companies said that all 24
